Selecta Biosciences, Inc. (NASDAQ:SELB) Q4 2022 Earnings Call Transcript

Page 7 of 7

But I don’t want to provide kind of specific guidance at this particular juncture on how to think about overall expenses. But hopefully, that gives a little bit of context in some of the moving parts as we think about 2023.

Operator: This concludes our question-and-answer session. I would like to turn the conference back over to Carsten Brunn for any closing remarks.

Carsten Brunn: Thank you, operator, and thank you to everyone who joined us this morning. Stay safe and healthy. This concludes today’s call. Thanks.

Follow Cartesian Therapeutics Inc.

Page 7 of 7